Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Evaluating Physical Properties of Ointment Samples – V 2.0

Posted on By

SOP for Evaluating Physical Properties of Ointment Samples – V 2.0

Procedure for Evaluating Physical Properties of Ointment Samples

Department Research and Development (R&D)/Quality Control
SOP No. FD-013
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to outline the procedure for evaluating the physical properties of ointment samples. This ensures product consistency, quality, and compliance with established specifications before further development or market release.

2. Scope

This SOP applies to all ointment samples prepared during research, development, and manufacturing. It covers tests for physical appearance, viscosity, spreadability, homogeneity, pH, and stability.

3. Responsibilities

  • Formulation Scientist: Prepares and submits samples for physical evaluation.
  • Quality Control (QC) Analyst: Conducts the tests and records observations.
  • Quality Assurance (QA) Personnel: Verifies compliance with the required specifications.
  • R&D Head: Reviews the evaluation data and approves further testing or modifications.
See also  Ointments: SOP for Approving QC Results - V 2.0

4. Accountability

The R&D and QC Managers are accountable for ensuring that all physical property evaluations are conducted according to this SOP and documented properly.

5. Procedure

5.1 Sample Preparation

  • Ensure that ointment samples are collected in clean, labeled containers.
  • Prepare at least three replicate samples to ensure test reproducibility.
  • Store samples under recommended temperature and humidity conditions before testing.

5.2 Physical Appearance

  • Visually inspect the sample for color, texture, and phase separation.
  • Record any visible defects such as air bubbles, crystallization, or contamination.

5.3 Viscosity Measurement

  • Use a Brookfield Viscometer or equivalent to measure viscosity.
  • Ensure that the instrument is calibrated before measurement.
  • Record the viscosity in centipoise (cP) and compare it with standard specifications.

5.4 Spreadability Test

  • Place 1 g of ointment between two glass slides.
  • Apply a standard weight and measure the diameter of the spread sample.
  • Record the spreadability index in mm.
See also  Ointments: SOP for QA Oversight During Packing Operations - V 2.0

5.5 Homogeneity Assessment

  • Take a small quantity of ointment on a glass plate.
  • Spread it uniformly and observe under a magnifying lens.
  • Ensure that there are no lumps, particles, or phase separation.

5.6 pH Measurement

  • Dissolve 1 g of ointment in 10 mL of distilled water.
  • Measure the pH using a calibrated pH meter.
  • Ensure that the pH falls within the specified range (e.g., 5.0-7.5).

5.7 Stability Testing

  • Store samples at different conditions:
    • 25°C ± 2°C / 60% RH
    • 40°C ± 2°C / 75% RH
    • Refrigerated conditions (2-8°C)
  • Observe any changes in color, texture, or phase separation over time.
  • Record and compare the results with initial observations.

5.8 Documentation and Reporting

  • Record all test results in the Ointment Evaluation Log.
  • Summarize the findings in an Evaluation Report.
  • QA personnel must verify and approve results before further testing or product modifications.

6. Abbreviations

  • QC – Quality Control
  • QA – Quality Assurance
  • R&D – Research and Development
  • RH – Relative Humidity
  • cP – Centipoise
See also  Ointments: SOP for Material Labeling Post-Weighing - V 2.0

7. Documents

  • Ointment Evaluation Log (Annexure-1)
  • Evaluation Report (Annexure-2)

8. References

  • ICH Q1A (R2) Stability Testing Guidelines
  • USP <911> Viscosity Guidelines
  • WHO GMP Guidelines for Pharmaceutical Manufacturing
  • 21 CFR Part 211 – Current Good Manufacturing Practices

9. SOP Version

Version 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Ointment Evaluation Log

Date Batch Number Test Parameter Specification Result Verified By
01/02/2025 OINT-001 Viscosity 1000-2000 cP 1500 cP QA Officer
02/02/2025 OINT-002 pH 5.5-7.5 6.2 QA Officer

Annexure-2: Evaluation Report

Date Batch Number Appearance Spreadability Stability Observation Final Status
01/02/2025 OINT-001 White, smooth 5 mm No changes Pass
02/02/2025 OINT-002 Yellowish, grainy 3 mm Separation observed Fail

12. Revision History:

Revision Date Revision No. Details of Revision Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP QA Head
01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

Post navigation

Previous Post: SOP for Establishing Dose-Response Curves in Preclinical Studies
Next Post: SOP for Recycling of Non-Hazardous Waste Materials

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

English
 - 
en
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version